Costa Rica is seeking a “special consideration” from the United States regarding newly imposed tariffs on its exports, a plea rooted in a long-standing economic partnership and the critical role Costa Rican medical device manufacturing plays in the health of American citizens. The move comes after the implementation of a 10% tariff on goods exported to the U.S., following a Supreme Court decision that invalidated a previously planned 15% tariff. This situation highlights the complex interplay between trade policy and public health, and the potential consequences of protectionist measures.
The request for preferential treatment, articulated by Costa Rican Minister of Foreign Trade Manuel Tovar, centers on the unique contribution Costa Rica makes to the U.S. Healthcare system. Tovar emphasized that Costa Rican-produced medical devices are not in competition with American manufacturers, but rather complement their efforts, ultimately saving lives. This argument is being presented as a matter of national security, framing access to medical technology as a vital component of public health and safety. The core of the dispute revolves around tariffs and their potential impact on the flow of essential medical supplies and other goods between the two nations.
Tariff Implementation and Potential Escalation
The current 10% tariff, which took effect this week, is a result of a legal challenge to a higher 15% tariff proposed by the Trump administration. According to reporting from The Tico Times, the initial 15% tariff was struck down by the Costa Rican Supreme Court. The current tariff is capped at 15% under the Federal Commerce Law, and is temporary, set to expire on July 24, 2026. Extending the tariff beyond this date would require legislative action in the U.S., a potentially significant political hurdle.
Even as the current tariff is 10%, there is concern that it could be raised to the maximum allowable 15%. Tovar acknowledged this possibility, stating that the increase “remains in the air, but has not been made official.” This uncertainty adds to the anxiety within Costa Rica, as a higher tariff would further strain the country’s export economy. The situation is further complicated by the fact that Costa Rica previously enjoyed more favorable tariff rates compared to regional competitors like the Dominican Republic and Panama, a situation the current tariff partially addresses.
Costa Rica’s Key Exports and Economic Impact
Costa Rica’s exports to the United States are diverse, encompassing agricultural products like melons, watermelons, coffee, pineapples, bananas, and tomatoes, as well as textiles and, crucially, medical devices. The tariff maintains exemptions for these agricultural products and pharmaceuticals, alongside the inclusion of textiles. The textile industry, while smaller than it once was, still supports an estimated 10,000 to 11,000 jobs in Costa Rica.
However, it is the medical device sector that is central to Costa Rica’s argument for special consideration. Costa Rica has become a significant hub for medical device manufacturing, attracting investment from major U.S. Companies. These facilities produce a range of products, including pacemakers, stents, and other life-saving technologies. The country’s skilled workforce, stable political environment, and strategic location have made it an attractive destination for this industry. According to the Costa Rican Coalition for Development Initiatives (CINDE), the medical device sector is one of the largest foreign direct investment recipients in the country.
The “Saving Lives” Argument and U.S. Healthcare
Minister Tovar’s assertion that “from Costa Rica, lives of North Americans are saved” underscores the critical role Costa Rican manufacturing plays in the U.S. Healthcare supply chain. The country’s medical device industry doesn’t aim to replace U.S. Production, but rather to supplement it, ensuring a consistent supply of essential medical technologies. This argument taps into the broader debate about the impact of trade policies on public health and national security.
The U.S. Relies heavily on imports for medical devices, and disruptions to the supply chain can have serious consequences for patient care. Tariffs can increase the cost of these devices, potentially limiting access for some patients. They can create uncertainty for manufacturers, leading to investment decisions that could ultimately harm the long-term availability of critical medical technologies. The Financial Times reported in February 2026 that U.S. Tariffs on medical devices would harm Americans’ health, echoing Costa Rica’s concerns. Read more from the Financial Times
CPTPP and Costa Rica’s Trade Strategy
Costa Rica is likewise actively pursuing membership in the Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP), a trade agreement that includes countries like Australia, Canada, Japan, and Mexico. According to Nikkei Asia, a deal is expected “in a few weeks.” Nikkei Asia reports on the CPTPP deal. Joining the CPTPP would diversify Costa Rica’s trade relationships and reduce its reliance on the U.S. Market, providing a buffer against potential trade disruptions. This strategic move demonstrates Costa Rica’s commitment to open trade and its efforts to secure its economic future.
Impact on Costa Rican Exports
Despite the imposition of the 10% tariff, Tovar reported that Costa Rican exports to the United States have continued to increase. He suggests that the cost of the tariff is being absorbed by importers or ultimately passed on to consumers in the U.S. This observation, while encouraging, does not negate the potential for long-term harm if the tariff is increased or prolonged. The continued flow of exports suggests a resilient market, but also highlights the potential for inflationary pressures on U.S. Consumers.
Looking Ahead
The situation remains fluid, with the possibility of the tariff increasing to 15% still looming. The expiration date of July 24, 2026, provides a clear deadline for a resolution, but any extension would require legislative action in the U.S. Congress. Costa Rica is actively engaging with U.S. Officials to advocate for a more favorable trade arrangement, emphasizing the mutually beneficial nature of the relationship and the critical role its medical device industry plays in supporting American healthcare.
The coming months will be crucial in determining the future of trade relations between Costa Rica and the United States. The outcome will not only impact the economies of both countries but also have implications for the broader debate about trade, public health, and national security. The next key development will be any official announcement from the U.S. Government regarding a potential increase in the tariff, or the initiation of legislative action to extend the current tariff beyond its expiration date.
What are your thoughts on the impact of tariffs on international trade and healthcare? Share your comments below and let us know how these developments affect you.